Abstract
Oral bisphosphonates are primarily used for treatment of osteoporosis and osteopenia, as well as some less common metabolic bone disorders including Paget’s disease of the bone, osteogenesis imperfecta, and fibrous dysplasia. Intravenous bisphosphonates are used for the management of cancer-related conditions, such as hypercalcemia of malignancy and skeletal complications associated with bone metastases in patients with solid tumors including breast, prostate, and lung cancer, and treatment of lytic lesions in patients with multiple myeloma.
Original language | English (US) |
---|---|
Title of host publication | Neuroimaging Pharmacopoeia |
Publisher | Springer International Publishing |
Pages | 351-358 |
Number of pages | 8 |
ISBN (Electronic) | 9783319127156 |
ISBN (Print) | 9783319127149 |
DOIs | |
State | Published - Jan 1 2015 |
ASJC Scopus subject areas
- General Medicine
- Pharmacology, Toxicology and Pharmaceutics(all)